Optimization of Statin-Loaded Delivery Nanoparticles for Treating Chronic Liver Diseases by Targeting Liver Sinusoidal Endothelial Cells
Authors:
- Mar GilMGMar Gil
- Lareen KhouriLKLareen Khouri
- Imma RaurellIRImma Raurell
- Diana RafaelDiana Rafael
- Fernanda AndradeFAFernanda Andrade
- Ibane AbasoloIAIbane Abasolo
- Simo SchwartzSimo Schwartz
- María Martínez-GómezMMMaría Martínez-Gómez
- María Teresa SalcedoMSMaría Teresa Salcedo
- Juan Manuel PericàsJPJuan Manuel Pericàs
- Diana HideDHDiana Hide
- Mingxing WeiMWMingxing Wei
Open Access
- 14 October 2023
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (10) , 2463
Abstract
In this study, we developed functionalized polymeric micelles (FPMs) loaded with simvastatin (FPM-Sim) as a drug delivery system to target liver sinusoidal endothelial cells (LSECs) for preserving liver function in chronic liver disease (CLD). Polymeric micelles (PMs) were functionalized by coupling peptide ligands of LSEC membrane receptors CD32b, CD36 and ITGB3. Functionalization was confirmed via spectroscopy and electron microscopy. In vitro and in vivo FPM-Sim internalization was assessed by means of flow cytometry in LSECs, hepatocytes, Kupffer and hepatic stellate cells from healthy rats. Maximum tolerated dose assays were performed in healthy mice and efficacy studies of FPM-Sim were carried out in bile duct ligation (BDL) and thioacetamide (TAA) induction rat models of cirrhosis. Functionalization with the three peptide ligands resulted in stable formulations with a greater degree of in vivo internalization in LSECs than non-functionalized PMs. Administration of FPM-Sim in BDL rats reduced toxicity relative to free simvastatin, albeit with a moderate portal-pressure-lowering effect. In a less severe model of TAA-induced cirrhosis, treatment with FPM-CD32b-Sim nanoparticles for two weeks significantly decreased portal pressure, which was associated with a reduction in liver fibrosis, lower collagen expression as well as the stimulation of nitric oxide synthesis. In conclusion, CD32b-FPM stands out as a good nanotransporter for drug delivery, targeting LSECs, key inducers of liver injury.Keywords
Funding Information
- Instituto de Salud Carlos III (ISCIII) (PI18/00947, AC18/00033 (ENM3 2018), PI21/00691, CB06/04/0007, CB06/01/0012, ERDF/ESF, 1388/22, 3-15199, 2021 SGR 532 01173)
- CIBER (PI18/00947, AC18/00033 (ENM3 2018), PI21/00691, CB06/04/0007, CB06/01/0012, ERDF/ESF, 1388/22, 3-15199, 2021 SGR 532 01173)
- ISCIII and cofounded by European Union (PI18/00947, AC18/00033 (ENM3 2018), PI21/00691, CB06/04/0007, CB06/01/0012, ERDF/ESF, 1388/22, 3-15199, 2021 SGR 532 01173)
- Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR) (PI18/00947, AC18/00033 (ENM3 2018), PI21/00691, CB06/04/0007, CB06/01/0012, ERDF/ESF, 1388/22, 3-15199, 2021 SGR 532 01173)
- Israel Science Foundation (PI18/00947, AC18/00033 (ENM3 2018), PI21/00691, CB06/04/0007, CB06/01/0012, ERDF/ESF, 1388/22, 3-15199, 2021 SGR 532 01173)
- Ministry of Health, State of Israel (PI18/00947, AC18/00033 (ENM3 2018), PI21/00691, CB06/04/0007, CB06/01/0012, ERDF/ESF, 1388/22, 3-15199, 2021 SGR 532 01173)
- Faculty of Mathematics and Natural Sciences (PI18/00947, AC18/00033 (ENM3 2018), PI21/00691, CB06/04/0007, CB06/01/0012, ERDF/ESF, 1388/22, 3-15199, 2021 SGR 532 01173)
- Catalan Government (PI18/00947, AC18/00033 (ENM3 2018), PI21/00691, CB06/04/0007, CB06/01/0012, ERDF/ESF, 1388/22, 3-15199, 2021 SGR 532 01173)
This publication has 45 references indexed in Scilit:
- Simvastatin Ameliorates Liver Fibrosis via Mediating Nitric Oxide Synthase in Rats with Non-Alcoholic Steatohepatitis-Related Liver FibrosisPLOS ONE, 2013
- Encapsulation of Hydrophobic Drugs in Pluronic F127 Micelles: Effects of Drug Hydrophobicity, Solution Temperature, and pHLangmuir, 2013
- Pharmacological Actions of Statins: A Critical Appraisal in the Management of CancerPharmacological Reviews, 2012
- Endothelial expression of transcription factor Kruppel-like factor 2 and its vasoprotective target genes in the normal and cirrhotic rat liverGut, 2010
- Pharmacological inhibition of integrin αvβ3 aggravates experimental liver fibrosis and suppresses hepatic angiogenesis #Hepatology, 2009
- Liver cirrhosisThe Lancet, 2008
- Enhanced vasoconstrictor prostanoid production by sinusoidal endothelial cells increases portal perfusion pressure in cirrhotic rat liversJournal of Hepatology, 2007
- Hyperlipidemia and surfactants: The liver sieve is a linkAtherosclerosis, 2006
- Sinusoidal endothelial COX-1-derived prostanoids modulate the hepatic vascular tone of cirrhotic rat liversAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2005
- Capillarization of Hepatic Sinusoid by Liver Endothelial Cell-Reactive Autoantibodies in Patients with Cirrhosis and Chronic HepatitisThe American Journal of Pathology, 2003